Related references
Note: Only part of the references are listed.Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease
Hong Ma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis
M. Nannipieri et al.
OBESITY SURGERY (2009)
Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implications
Emmanuel A. Tsochatzis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
J. A. Seo et al.
CLINICAL ENDOCRINOLOGY (2008)
Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH
Giovanni Musso et al.
HEPATOLOGY (2008)
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice
Kengo Tomita et al.
HEPATOLOGY (2008)
Adipocytokines and liver disease
Yoshihiro Kamada et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
Zobair M. Younossi et al.
OBESITY SURGERY (2008)
Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity
Emmanuel Tsochatzis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
The treatment with antibody of TNF-α reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet
Suleyman Serdar Koca et al.
INFLAMMATION (2008)
Adipokines and cytokines in non-alcoholic fatty liver disease
M. H. Jarrar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis
E. Tsochatzis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model
Yoshihiro Kamada et al.
JOURNAL OF HEPATOLOGY (2007)
Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis
Masahiko Shimada et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future
Anna Wieckowska et al.
HEPATOLOGY (2007)
Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone
Aiwei Yao-Borengasser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass
Nora Kloeting et al.
CELL METABOLISM (2007)
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis
Sanjaya K. Satapathy et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation
Prabhakaran Balagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity
George V. Papatheodoridis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients
David Garcia-Galiano et al.
OBESITY SURGERY (2007)
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Katsutoshi Tokushige et al.
JOURNAL OF HEPATOLOGY (2007)
Resistin as an intrahlepatic cytokine -: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells
Cristiana Bertolani et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The evolving role of leptin and adiponectin in chronic liver diseases
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice
Narci Teoh et al.
JOURNAL OF HEPATOLOGY (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Increased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease
J Poniachik et al.
CYTOKINE (2006)
Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
K Tomita et al.
GUT (2006)
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
C Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
XL Jin et al.
HEPATOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
S Abiru et al.
LIVER INTERNATIONAL (2006)
High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection
AYH Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Adipokines in NASH:: Postprandial lipid metabolism as a link between adiponectin and liver disease
G Musso et al.
HEPATOLOGY (2005)
Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin
R Palanivel et al.
FEBS LETTERS (2005)
Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway
N Silswal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice
M You et al.
HEPATOLOGY (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Resistin, an adipokine with potent proinflammatory properties
M Bokarewa et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation of SOCS-3 by resistin
CM Steppan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Adiponectin and its receptors in non-alcoholic steatohepatitis
S Kaser et al.
GUT (2005)
Abnormal glucose homeostasis due to chronic hyperresistinemia
SM Rangwala et al.
DIABETES (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Adenovirus-mediated chronic hyper-resistinemia leads to in vivo insulin resistance in normal rats
H Satoh et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
P Angulo et al.
JOURNAL OF HEPATOLOGY (2004)
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
T Masaki et al.
HEPATOLOGY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
AE Feldstein et al.
HEPATOLOGY (2004)
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
S Naveau et al.
HEPATOLOGY (2004)
Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats
S Shklyaev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat
M Pravenec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin 6 is important for survival after partial hepatectomy in mice
A Blindenbacher et al.
HEPATOLOGY (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Resistin is expressed in human macrophages and directly regulated by PPARγ activators
L Patel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
S Chitturi et al.
HEPATOLOGY (2002)
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat
K Ikejima et al.
GASTROENTEROLOGY (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Leptin in hepatic fibrosis:: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
NK Saxena et al.
HEPATOLOGY (2002)
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti et al.
GASTROENTEROLOGY (2002)
Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals
K Ikejima et al.
HEPATOLOGY (2001)
Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
T Kakuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
